109313 ⎘
Active agents used in cell culture processes, e.g. differentation; Cytokines; Chemokines Chemokines, e.g. MIP-1, MIP-2, RANTES, MCP, PF-4
COMPOSITIONS FOR PROMOTING ACTIVATION OF BONE MARROW-DERIVED STEM CELLS COMPRISING CCL5
#2Method for screening, activating, amplifying and cryopreserving mesenchymal stem cells in vitro and establishing cell bank of mesenchymal stem cells
#3A METHOD FOR PRODUCING iPS CELL-DERIVED NATURAL KILLER CELLS
#4TREATMENT OF THE CORNEAL ENDOTHELIUM
#5METHOD OF USING FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS TO INCREASE COLLAGEN AND ELASTIN IN HUMAN SKIN
#6METHOD FOR INDUCING DEDIFFERENTIATION OF ADIPOCYTES
#7NK CELLS WITH AN INCREASED ANTIBODY-DEPENDENT CELLULAR TOXICITY (ADCC) AGAINST TUMORS
#8GENERATION OF MATRIX-BOUND NANOVESICLES FROM HUMAN BRAIN ORGANOIDS
#9PRODUCTION METHOD FOR SHEET-LIKE RETINAL TISSUE
#10METHODS FOR PRODUCING MATURE CHONDROCYTE AND COMPOSITION CONTAINING MATURE CHONDROCYTE
#11HUMAN CEREBELLAR ORGANOIDS WITH BONA FIDE PURKINJE CELLS AND USES THEREOF
#12CELL COMPOSITIONS COMPRISING ANTIGEN-SPECIFIC T CELLS FOR ADOPTIVE THERAPY
#13HYBRID ALLOSTERIC RECEPTOR-ENGINEERED STEM CELLS
#14METHODS FOR SPERMATOGONIAL CULTURE
#15EXPANSION OF GAMMA DELTA T CELLS, COMPOSITIONS, AND METHODS OF USE THEREOF
#16CRANIAL NERVE DISORDER THERAPEUTIC AGENT INCLUDING CULTURE SUPERNATANT OF TISSUE CELLS DERIVED FROM FETAL APPENDAGE
#17A SYNTHETIC HYDROGEL AND ITS USE FOR IMMUNOTHERAPY AND 3D-PRINTING
#18METHOD FOR PRODUCING MATURE ADIPOCYTE-CONTAINING COMPOSITION
#19NATURAL KILLER CELLS AND ILC3 CELLS AND USES THEREOF
#20COMPOSITION FOR ENHANCING REPROGRAMMING EFFICIENCY FROM SOMATIC CELL TO INDUCED PLURIPOTENT STEM CELL, COMPRISING MTOR ACTIVATOR, AND METHOD FOR ENHANCING REPROGRAMMING EFFICIENCY BY USING SAME
#21CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#22ENGINEERED OFF-THE-SHELF IMMUNE CELLS AND METHODS OF USE THEREOF
#23COMPOSITIONS AND METHODS FOR GENERATION OF HEART FIELD-SPECIFIC PROGENITOR CELLS
#24FACTOR RICH PRODUCTS FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
#25NOVEL METHOD FOR PRODUCING ANTIBODIES
#26A METHOD FOR INCREASING POPULATION OF SPERMATOGONIAL STEM CELLS
#27METHODS AND COMPOSITIONS RELATED TO PLATELET RELEASATE AND PLATELET-RICH FIBRIN
#28FACTOR RICH PRODUCT FROM UMBILICAL CORD MESENCHYMAL STEM CELLS
#29Cellular Targeted Label Delivery System
#30CAR-T LYMPHOCYTES ENGINEERED TO HOME TO LYMPH NODE B CELL ZONE, SKIN, OR GASTROINTESTINAL TRACT
#31UMBILICAL CORD LINING STEM CELLS AND CONDITIONED MEDIA THEREOF
#32METHOD OF INDUCING DEDIFFERENTIATION OF SOMATIC CELLS WITH SMALL MOLECULES TO PREPARE REJUVENATED MESENCHYMAL STEM CELLS AND USES THEREOF
#33METHOD AND APPARATUS FOR PRODUCING PLATELET AND METHOD FOR DETERMINING OPERATING CONDITION OF APPARATUS FOR PRODUCING PLATELET
#34Expansion of γδ T cells, compositions, and methods of use thereof
#35EX VIVO NK CELL DIFFERENTIATION FROM CD34+ HEMATOPOIETIC CELLS
#36STEM CELL MATERIAL AND METHOD OF MANUFACTURING
#37NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
#38TREATMENT OF LIVER FAILURE WITH ACTIVATED T REGULATORY CELLS
#39Composition having tissue-repairing activity, and use therefor
#40METHODS OF EXTRACTING HEMATOPOIETIC CELLS FROM BONE MARROW EX VIVO
#41Methods of culturing t cells and uses of same
#42Method to obtain lymphoid progenitors
#43Pancreatic endocrine cells and methods thereof
#44Cellular targeted active ingredient delivery system
#45Method for producing CD4/CD8 double-positive T cells
#46CELLULAR TARGETED PHARMACEUTICALLY ACTIVE SUBSTANCE OR LABEL DELIVERY SYSTEM
#47Generation of cancer stem cells and use thereof
#48Postpartum cells derived from placental tissue, and methods of making and using the same
#49In vitro neonatal biomimetic (nMIMIC) model and methods of using same
#50CELL COMPOSITIONS COMPRISING ANTIGEN-SPECIFIC T CELLS FOR ADOPTIVE THERAPY
#51Bovine serum composition and method for culturing cells using said bovine serum composition as additive
#52Soft tissue repair and regeneration using postpartum-derived cells and cell products
#53NK cells with an increased antibody-dependent cellular toxicity (ADCC) against tumors
#54Composition having tissue-repairing activity, and use therefor
#55High throughput 3D assay for immune cell and drug homing, migration and tumor cytotoxicity
#56METHODS OF MESENCHYMAL STEM CELL MOBILIZATION AND EXPANSION
#57Ex vivo NK cell differentiation from CD34 hematopoietic cells
#58Pancreatic endocrine cells and methods thereof
#59Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#60Stem cell material and method of manufacturing
#61BIOACTIVE COMPOSITIONS DERIVABLE FROM PLATELET CONCENTRATES, AND METHODS FOR PREPARING AND USING SAME
#62Culture media for multipotent stem cells
#63Method for producing cerebellar progenitor tissue
#64Postpartum cells derived from placental tissue, and methods of making and using the same
#65Composition and Methods of Using Umbilical Cord Lining Stem Cells
#66Postpartum cells derived from placental tissue, and methods of making and using the same
#67Postpartum cells derived from placental tissue, and methods of making and using the same
#68Method for inducing ectodermal differentiation of embryoid bodies derived from human pluripotent stem cells by CXCR2 stimulation
#69Method of making conditioned medium from immortalized dental pulp stem cells
#70Feeder-free method for culture of bovine and porcine spermatogonial stem cells
#71Repair and regeneration of ocular tissue using postpartum-derived cells
#72Muscle stem cell in vitro culture method and application
#73Megakaryocyte and platelet production from stem cells
#74METHODS FOR INDUCTION OF CELL FATES FROM PLURIPOTENT CELLS
#75Composition having tissue-repairing activity, and use therefor
#76RNA preparations comprising purified modified RNA for reprogramming cells
#77Differentiation of human embryonic stem cells
#78Feeder-free method for culture of bovine and porcine spermatogonial stem cells
#79Hydrogel-based vascular lineage cell growth media and uses thereof
#80Use of SDF-1 to improve ischemic myocardial function
#81Repair and regeneration of ocular tissue using postpartum-derived cells
#82EX VIVO NK CELL DIFFERENTIATION FROM CD34+ HEMATOPOIETIC CELLS
#83Artificial immune system: methods of use
#84Methods for testing an immune response using cultures of T cells, B cells, dendritic cells and follicular dendritic cells
#85Regeneration and repair of neural tissue using postpartum-derived cells
#86Generation of NK cells and NK-cell progenitors
#87Immunosuppressive cells and methods of making and using thereof
#88PDGF induced cell homing
#89Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#90Feeder-free method for culture of bovine and porcine spermatogonial stem cells
#91Use of entrained neutrophils to treat metastatic and micrometastatic disease in at risk patients
#92Use of CCL1 in therapy
#93Regeneration and repair of neural tissue using postpartum-derived cells
#94Tooth scaffolds
#95Method for inducing migration of adipose-derived adult stem cells
#96Megakaryocyte and platelet production from stem cells
#97Hydrogel-based vascular lineage cell growth media and uses thereof
#98Method of treating autoimmune disease with mesenchymal stem cells
#99Methods for testing an immune response using cultures of T cells, B cells and dendritic cells
#100Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
#101Methods of evaluating a test agent in a diseased cell model
#102Methods for assaying responses to vaccines
#103Stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them
#104Methods of evaluating an immune response to an antigen
#105PURGING OF AN EX VIVO HEMATOPOIETIC STEM CELL CULTURE OF CANCER CELLS
#106Treatment of amyotrophic lateral sclerosis using umbilical derived cells
#107Human bone marrow microenvironments and uses thereof
#108Artificial immune system: methods for making and use
#109TREATMENT OF LIQUID CANCERS
#110METHODS OF USING ISOLATED RECOMBINANT POLYPEPTIDE ANTAGONISTS OF SDF-1
#111Methods of evaluating a test agent in a diseased cell model
#112Repair and regeneration of ocular tissue using postpartum-derived cells
#113Method for efficient production of monocyte-derived multipotent cell (MOMC)
#114Regeneration and repair of neural tissue using postpartum-derived cells
#115Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells
#116Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#117Use of SDF-1 to improve ischemic myocardial function
#118In vitro germinal centers
#119Methods for antibody production
#120Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells
#121Method for determining the immunogenicity of an antigen
#122Disease model incorporation into an artificial immune system (AIS)
#123Growth Factor Supplement for Stem Cell Cultures
#124Differentiation of human embryonic stem cells
#125METHOD OF TREATING AUTOIMMUNE DISEASE WITH MESENCHYMAL STEM CELLS
#126CXCR4 ANTAGONIST TREATMENT OF HEMATOPOIETIC CELLS
#127Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
#128Method for determining the immunogenicity of an antigen
#129Methods and means for stem cell proliferation and subsequent generation and expansion of progenitor cells, as well as production of effector cells as clinical therapeutics
#130Disease model incorporation into an artificial immune system (AIS)
#131DNA ENCODING FOR RECOMBINANT POLYPEPTIDE EMUTANTS OF HUMAN STROMAL CELL-DERIVED FACTOR 1
#132Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
#133Stem Cells Suitable for Transplantation, their Preparation and Pharmaceutical Compositions Comprising Them
#134Genetically engineered cells for therapeutic applications
#135Genetically engineered cells for therapeutic applications
#136In vitro germinal centers
#137Co-culture lymphoid tissue equivalent (LTE) for an artificial immune system (AIS)
#138Methods of ex vivo hematopoietic stem cell expansion by co-culture with mesenchymal cells
#139Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#140Disease model incorporation into an artificial immune system (AIS)
#141Artificial lymphoid tissue equivalent
#142Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#143Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
#144In vitro mucosal tissue equivalent
#145Automatable artificial immune system (AIS)
#146Repair and regeneration of ocular tissue using postpartum-derived cells
#147Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
#148Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
#149CCR ligands for stem cell homing
#150Cartilage and bone repair and regeneration using postpartum-derived cells
#151Method of differentiating umbilical cord tissue into a chondrogenic phenotype
#152Cartilage and bone repair and regeneration using postpartum-derived cells
#153Cartilage and bone repair and regeneration using postpartum-derived cells
#154Soft tissue repair and regeneration using postpartum-derived cells and cell products
#155Use of SDF-1 or G-CSF to improve myocardial function after ischemic injury
#156CXCR4 antagonist treatment of hematopoietic cells
#157Artificial immune system: methods for making and use
#158Material and methods for the growth of hematopoietic stem cells
#159Genetically engineered cells for therapeutic applications
#160Cell culture environments for the serum-free expansion of mesenchymal stem cells
#1616-O-sulfated N-acetylheparosan and hematopoietic stem cell growth auxiliary agent
#162Postpartum cells derived from placental tissue, and methods of making and using the same
#163Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
#164Soft tissue repair and regeneration using postpartum-derived cells
#165Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same
#166Treatment of retinitis pigmentosa with human umbilical cord cells
#167Regeneration and repair of neural tissue using postpartum-derived cells
#168Cartilage and bone repair and regeneration using postpartum-derived cells
#169Methods for isolation of osteoclast precursor cells and inducing their differentiation into osteoclasts